Adze Biotechnology Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Private

  • Employees
  • 2

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $9.3M

  • Investors
  • 1

Adze Biotechnology General Information

Description

Developer of oncologic immunotherapies designed to help in the treatment of cancers with significant unmet needs. The company's immunotherapies harness immune response mechanisms and target immune stimulatory and inhibitory receptors, dendritic cells, and macrophages to further amplify the immune response, enabling healthcare professionals to increase patient survival and improve patient quality of life through reduced side effects.

Contact Information

Formerly Known As
Virion Biotechnology
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 2332 Galiano Street
  • Second Floor
  • Coral Gables, FL 33134
  • United States
+1 (917)
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Corporate Office
  • 2332 Galiano Street
  • Second Floor
  • Coral Gables, FL 33134
  • United States
+1 (917)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Adze Biotechnology Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Later Stage VC (Series A) 13-Nov-2026 $9.3M Completed Clinical Trials - Phase 1
1. Seed Round 19-May-2022 Completed Pre-Clinical Trials
To view Adze Biotechnology’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Adze Biotechnology Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of oncologic immunotherapies designed to help in the treatment of cancers with significant unmet needs. The co
Drug Discovery
Coral Gables, FL
2 As of 2021

Andover, MA
 

Woburn, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Adze Biotechnology Competitors (3)

One of Adze Biotechnology’s 3 competitors is Oncorus, a Formerly VC-backed company based in Andover, MA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Oncorus Formerly VC-backed Andover, MA
Replimune Formerly VC-backed Woburn, MA
Akamis Bio Venture Capital-Backed Abingdon, United Kingdom
You’re viewing 3 of 3 competitors. Get the full list »

Adze Biotechnology Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Adze Biotechnology Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds
Matter (Consulting Services (B2B)) Accelerator/Incubator Minority
To view Adze Biotechnology’s complete investors history, request access »

Adze Biotechnology FAQs

  • When was Adze Biotechnology founded?

    Adze Biotechnology was founded in 2018.

  • Where is Adze Biotechnology headquartered?

    Adze Biotechnology is headquartered in Coral Gables, FL.

  • What is the size of Adze Biotechnology?

    Adze Biotechnology has 2 total employees.

  • What industry is Adze Biotechnology in?

    Adze Biotechnology’s primary industry is Drug Discovery.

  • Is Adze Biotechnology a private or public company?

    Adze Biotechnology is a Private company.

  • What is Adze Biotechnology’s current revenue?

    The current revenue for Adze Biotechnology is .

  • How much funding has Adze Biotechnology raised over time?

    Adze Biotechnology has raised $12.9M.

  • Who are Adze Biotechnology’s investors?

    Matter (Consulting Services (B2B)) has invested in Adze Biotechnology.

  • Who are Adze Biotechnology’s competitors?

    Oncorus, Replimune, and Akamis Bio are competitors of Adze Biotechnology.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process